The effects of synbiotics supplement on item of metabolic syndrome

Phase 2

• Conditions: Metabolic syndrome.; Metabolic disorder, unspecified; E88.9

• Registration Number: IRCT20170501033747N2
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 December 2019

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Age range 10 to 18 years
A parent's willingness to participate in the study and sign the informed consent form
Has at least one item of metabolic syndrome
Failure to participate in weight loss programs for the past 6 months

Exclusion Criteria

Unwillingness to continue attending the study
Non-compliance with intervention (less than 90% product use)
Major change in energy intake and nutrient intake or consumption of less than 800 kcal and more than 4200 kcal during the study based on the 3-day food registration method
Start any weight loss or weight gain diet during the study
Individual tobacco use during the study
Use of antioxidants, multivitamins or any dietary supplements during intervention
Antibiotic use during the study
People with mental illnesses, cardiovascular, lung, liver, kidney, cancer, thyroid and eating disorders
Type 1 diabetic patients with insulin and hypoglycemic drugs
People taking drugs that affect appetite, body weight, blood sugar, lipid profile or anti-inflammatory drugs

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changes in anthropometric indices and body composition. Timepoint: The beginning and the end of the study. Method of measurement: body composition analysis.

Secondary Outcome Measures

Name	Time	Method
Abdominal Volume Index and Conicity Index and A Body Shape Index. Timepoint: The beginning and the end of the study. Method of measurement: equation.